These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8167040)

  • 1. [The role of elective neck dissection in the surgical treatment of supraglottic carcinoma].
    Zhao SW
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(4):216-8, 252. PubMed ID: 8167040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of upper jugular node dissection in the management of supraglottic cancer of N0 category].
    Xu ZG
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(4):213-5, 251. PubMed ID: 8167039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cervical lymph node metastasis and recurrence in supraglottic carcinoma after operation].
    Pan Z; Cao Z; Liu B
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):108-10. PubMed ID: 12764862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective neck dissection (IIA, III): a rational replacement for complete functional neck dissection in patients with N0 supraglottic and glottic squamous carcinoma.
    Ferlito A; Silver CE; Rinaldo A
    Laryngoscope; 2008 Apr; 118(4):676-9. PubMed ID: 18182969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of routine bilateral neck dissection in the management of the N0 neck in T1-T2 unilateral supraglottic cancer.
    Rodrigo JP; Cabanillas R; Franco V; Suárez C
    Head Neck; 2006 Jun; 28(6):534-9. PubMed ID: 16419080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elective lateral neck dissection for laryngeal cancer in the clinically negative neck.
    Zhang B; Xu ZG; Tang PZ
    J Surg Oncol; 2006 May; 93(6):464-7. PubMed ID: 16615158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lateral neck dissection vs radical neck dissection in the management of supraglottic carcinoma with pathologically negative nodes].
    Zhang B; Xu ZG; Tang PZ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Dec; 38(6):426-9. PubMed ID: 15040103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neck dissection of Levels II and III for the treatment of supraglottic laryngeal cancer with clinically negative neck].
    Jia SS; Wang YY; He HJ; Xiang C
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Sep; 45(9):747-50. PubMed ID: 21092673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of N0 neck in laryngeal carcinoma. Impact on patient's survival.
    Pinilla M; González FM; López-Cortijo C; Arellano B; Herrero J; Trinidad A; Vergara J
    J Laryngol Otol; 2003 Jan; 117(1):63-6. PubMed ID: 12590859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is dissection of level IV absolutely necessary in elective lateral neck dissection for clinically N0 laryngeal carcinoma?
    Lim YC; Choi EC; Lee JS; Koo BS; Song MH; Shin HA
    Oral Oncol; 2006 Jan; 42(1):102-7. PubMed ID: 16143563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elective treatment of the neck in squamous cell carcinoma of the larynx: clinical experience.
    Spriano G; Piantanida R; Pellini R; Muscatello L
    Head Neck; 2003 Feb; 25(2):97-102. PubMed ID: 12509791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine inclusion of level IV in neck dissection for squamous cell carcinoma of the larynx: is it justified?
    Khafif A; Fliss DM; Gil Z; Medina JE
    Head Neck; 2004 Apr; 26(4):309-12. PubMed ID: 15054733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
    Xie M; Sun Y; Li Y
    Laryngoscope; 2004 Dec; 114(12):2243-8. PubMed ID: 15564854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation.
    Lim YC; Lee JS; Koo BS; Kim SH; Kim YH; Choi EC
    Laryngoscope; 2006 Mar; 116(3):461-5. PubMed ID: 16540910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cervical metastasis in patients with T2-4 cN0 laryngeal carcinoma].
    Jia SS; He HJ; Xiang C; Liu WS
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 39(1):24-7. PubMed ID: 15127564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of sentinel node technique in the treatment of N0 supraglottic laryngeal cancer.
    Lawson G; Matar N; Nollevaux MC; Jamart J; Krug B; Delos M; Remacle M; Borght TV
    Laryngoscope; 2010 Nov; 120(11):2213-7. PubMed ID: 20949579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neck relapse-related factors of cN0 stage supraglottic cancer].
    Yu WB; Zeng ZY; Chen FJ; Zhang Q
    Ai Zheng; 2006 Mar; 25(3):355-8. PubMed ID: 16536994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment and results of N1 supraglottic laryngeal carcinoma].
    Tong K; Tu G
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(5):307-9. PubMed ID: 9642369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution of lymph node metastases in supraglottic squamous cell carcinoma: therapeutic implications.
    Redaelli de Zinis LO; Nicolai P; Tomenzoli D; Ghizzardi D; Trimarchi M; Cappiello J; Peretti G; Antonelli AR
    Head Neck; 2002 Oct; 24(10):913-20. PubMed ID: 12369069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.